Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04016116
Title Dual PD-1 and JAK2 Inhibition in Hematological Malignancies
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors NYU Langone Health
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.